Karyopharm Therapeutics (KPTI) Stock Price, News, Quotes-Moomoo

$Karyopharm Therapeutics (KPTI.US)$
Karyopharm Announces Favorable Change in Co-Primary Endpoint for Pivotal Phase 3 SENTRY Trial in Myelofibrosis
Karyopharm Therapeutics (Nasdaq: KPTI)announced a change in co-primary endpoint for its Phase 3 SENTRY Trial in myelofibrosis, replacing TSS50 with Absolute Total Symptom Score (Abs-TSS) following FDA feedback. The trial's sample size will increase to approximately 350 patients, with top-line data expected in 2H 2025.
Phase 1 trial data showed pr...

Trytosaveabit

Oct 31 06:35

Update

$Karyopharm Therapeutics (KPTI.US)$ Reuters· 5 mins ago
Karyopharm Announces Favorable Change in Co-Primary Endpoint for Pivotal Phase 3 Sentry Trial in Myelofibrosis

QMengColdJoke

Aug 29 15:40

Yeah CFO is gone, just hire someone on street!

$Karyopharm Therapeutics (KPTI.US)$ This dude was hired when stock price was 10 dollar. Now we are screwed. looks like a let resign. He’s good controller but probably a really bad CFO.

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

KPTI Karyopharm Therapeutics

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target